Skip to content
temoporfin

Structure via PubChem · Public domain (PubChem)

EntityQ7698204· pop 6· linked from 275 articles

temoporfin

Sign in to save

Also known as meso-tetrahydroxyphenylchlorin, 2,3-dihydro-5,10,15,20-tetra(m-hydroxyphenyl)porphyrin, m-THPC

Temoporfin (INN) is a photosensitizer (based on chlorin) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck. It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.

In the Vinony graph

Vinony's link graph records 275 inbound references to temoporfin, and connects out to tiazofurin, European Union and digital object identifier.

It sits within the topics Chemical pages without DrugBank identifier, Drug has EMA link and Drugs with non-standard legal status.

Vinony links it to 6 Wikipedia language editions.

Chemical data

Formula
C44H32N4O4
Molecular weight
680.7 g/mol
IUPAC name
3-[10,15,20-tris(3-hydroxyphenyl)-2,3,22,24-tetrahydroporphyrin-5-yl]phenol
SMILES
C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O
InChIKey
LYPFDBRUNKHDGX-UHFFFAOYSA-N
XLogP
8.8
Polar surface area
138 Ų
H-bond donors
6
H-bond acceptors
6
Formal charge
0

via PubChem

Research

558 papers

via PubMed

Wikidata facts

Mass
680.242355504
Has use
medication
Show 4 more facts
chemical formula
C₄₄H₃₂N₄O₄
canonical SMILES
C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O
NCI Thesaurus ID
C1669
subject has role
photosensitizer
Sources (3)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • References
  • Further reading

Temoporfin (INN) is a photosensitizer (based on chlorin) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck. It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.

Good results were obtained in 21 of 35 patients treated in Germany.

Excerpted from Wikipedia’s “temoporfin” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0

Connections

Categories